AG Eden / Frey
Publikationen
Grundlagenwissenschaftliche Arbeiten der AG Eden/Frey, neueste zuerst. Alle Angaben sind gegen PubMed, Crossref bzw. bioRxiv geprüft; klinische Publikationen finden Sie auf PubMed.
32 AG-geführte Originalarbeiten
Gezählt werden grundlagenwissenschaftliche Originalarbeiten mit Norbert Frey oder Matthias Eden als Erst-, Letzt- oder Korrespondenzautor sowie Arbeiten von Gruppenleitern aus der AG mit Norbert Frey als Vorletztautor. Kooperationen, Übersichtsarbeiten und Preprints sind gelistet, aber nicht gezählt.
2026
Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases
Strip1 Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy
FYCO1 improves postischemic cardiac remodeling via enhanced autophagic flux and attenuation of proinflammatory signaling
Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1alpha inhibition and drives heart failure
Multicellular signaling and partial recovery define reverse cardiac remodeling
2025
Deficiency for MicroRNA-582 does not impact dilated cardiomyopathy or heart failure induced by pressure overload in vivo
A cross-study transcriptional patient map of heart failure defines conserved multicellular coordination in cardiac remodeling
Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes
AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model
TRIM24 regulates chromatin remodeling and calcium dynamics in cardiomyocytes
DOI: 10.1186/s12964-025-02323-8PMID: 40598158Korrektur: 10.1186/s12964-025-02352-3
2024
Mst4, a novel cardiac STRIPAK complex-associated kinase, regulates cardiomyocyte growth and survival and is upregulated in human cardiomyopathy
2023
Fibin regulates cardiomyocyte hypertrophy and causes protein-aggregate-associated cardiomyopathy in vivo
2022
SRF: a seriously responsible factor in cardiac development and disease
2021
SH3-Binding Glutamic Acid Rich-Deficiency Augments Apoptosis in Neonatal Rat Cardiomyocytes
FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo
Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy
2020
Dysbindin deficiency Alters Cardiac BLOC-1 Complex and Myozap Levels in Mice
The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice
2019
A cardiac alpha-actin (ACTC1) p. Gly247Asp mutation inhibits SRF-signaling in vitro in neonatal rat cardiomyocytes
Rho-family GTPase 1 (Rnd1) is a biomechanical stress-sensitive activator of cardiomyocyte hypertrophy
Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure
A systematic view on E3 ligase Ring TRIMmers with a focus on cardiac function and disease
2017
MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2
The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling
TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels
Myeloid leukemia factor-1 is a novel modulator of neonatal rat cardiomyocyte proliferation
2016
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression
DOI: 10.1038/ncomms11317PMID: 27122098Korrektur: 10.1038/ncomms11835
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling
Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and beta-Catenin/GSK-3beta Protein Signaling
2015
Heat-shock-protein 90 protects from downregulation of HIF-1alpha in calcineurin-induced myocardial hypertrophy
2014
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction
Mice with cardiac-restricted overexpression of Myozap are sensitized to biomechanical stress and develop a protein-aggregate-associated cardiomyopathy
2010
Myomasp/LRRC39, a heart- and muscle-specific protein, is a novel component of the sarcomeric M-band and is involved in stretch sensing
2009
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy
2008
Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation
2006
Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy
2004
Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress
Hypertrophy of the heart: a new therapeutic target?
2003
Cardiac hypertrophy: the good, the bad, and the ugly
2002
Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins
2000
Calsarcins, a novel family of sarcomeric calcineurin-binding proteins
Decoding calcium signals involved in cardiac growth and function
Vollständige Publikationsliste auf PubMed einsehen
PubMed-Profil